Adc Therapeutics SA (ADCT) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.67
-0.45
-0.22
0

Details

Expected EPS
-0.44
Actual EPS
-0.37
Surprise EPS
0.07
Surprise Percent
+15.91%

Description

Adc Therapeutics SA (ADCT) has reported earnings of -0.37 per share for Q2 2023.

0 Comments

Share your thoughts